1227
One week after the initial-dose of adalimumab (160 mg), which was initiated due to an acute exacerbation of Crohn's disease, the patient developed a fulminant cardiomyopathy.
 an acute exacerbation of Crohn's disease, the patient: Subject; fulminant cardiomyopathy: Effect; One week after the initial-dose of adalimumab (160 mg): Treatment; Crohn's disease: Treatment.Disorder; adalimumab: Treatment.Drug; 160 mg: Treatment.Dosage; One week: Treatment.Time_elapsed
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 an acute exacerbation of Crohn's disease, the patient: Subject; fulminant cardiomyopathy: Effect; One week after the initial-dose of adalimumab (160 mg): Treatment; Crohn's disease: Treatment.Disorder; adalimumab: Treatment.Drug; 160 mg: Treatment.Dosage; One week: Treatment.Time_elapsed